# A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma

> **NCT03444948** · NA · SUSPENDED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 108 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DEVICE:** EUS-RFA using Habib Tm as a probe
- **PROCEDURE:** EUS

## Key facts

- **NCT ID:** NCT03444948
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-02-14
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-01
- **Target enrollment:** 108 (ESTIMATED)
- **Why stopped:** There was a voluntary recall from the Habib EUS RFA device manufacturer
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03444948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03444948, "A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03444948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*